Loading...
Keywords
Last Name
Institution

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.

Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J. 2007 Dec; 26(12):1089-93.

View in: PubMed

collapse authors with profiles